Executive Profile

Daniel L. Kisner M.D. Consultant and Director, Adaptive Therapeutics, Inc.

Age	Total Calculated Compensation	This person is connected to 12 Board Members in 12 different organizations across 19 different industries. See Board Relationships
65	--

Background

Dr. Daniel L. Kisner serves as a Consultant of Adaptive Therapeutics, Inc. Dr. Kisner is a Venture Partner at Biology. Since joining the Biology, Dr. Kisner has been involved in assessing and analyzing progress across the entire biopharma portfolio. Dr. Kisner serves as Administrative Director of Surgery at Franklin Square Hospital Center, Inc. Dr. Kisner served as a Venture Partner at Aberdare Ventures. Dr. Kisner has a long history of leading venture-backed companies. ... He served as the President and Chief Executive Officer at Caliper Life Sciences Inc. from February 1999 to July 2002. Dr. Kisner led Caliper from a technology-focused start up to a publicly traded commercially oriented organization. He served as the President and Chief Operating Officer at Isis Pharmaceuticals Inc. since February 1993 and the President from May 1994 to January 1999. Dr. Kisner was also an Executive Vice President of Isis Pharmaceuticals and was responsible for business and product development and manufacturing from March 1991 to February 1993. He was at Trine Pharmaceuticals, Inc. Earlier, He was the Division Vice President of Pharmaceutical Development at Abbott Laboratories from December 1988 to March 1991. Dr. Kisner also served as the Vice President of International Clinical Research and Development for Smith Kline & French Laboratories from March 1988 to November 1988 and served as its Vice President of Clinical Research and Development and Continental Europe from May 1985 to March 1988. Dr. Kisner serves as the Chairman of Sequoia Pharmaceuticals, Inc. and Avera Pharmaceuticals, Inc. He has been the Chairman of Tekmira Pharmaceuticals Corp. since January 28, 2010. He served as the Chairman of Caliper Life Sciences Inc. since July 1, 2002 and its Director since April 1, 1999. He has been a Member of the Board at Kémia, Inc., since August 11, 2005. He serves as a Director of Adaptive Therapeutics, Inc., BioVerdant, Inc., Symphony Allegro, Inc. and Ontogen Corporation. He has been a Director of Dynavax Technologies Corporation since July 22, 2010. Dr. Kisner has been an Independent Director of Lpath Inc since August 1, 2012. Dr. Kisner serves as a Director of Amphora Discovery Corp. He has been a Director of Tolerx, Inc. since April 2001. Dr. Kisner has been a Director of Anesta Corp. since February 1996. He has been a Director of Isis Pharmaceuticals Inc. since March 1991. Dr. Kisner sits on the Boards of several private companies. Previously, he served as an Independent Director of Sequenom Inc., from May 30, 2003 to June 13, 2005 and was a Member of Compensation and Audit Committees. He served as a Director of Mpex Pharmaceuticals, Inc. since August 11, 2005 and KAI Pharmaceuticals, Inc. since May 2006. Dr. Kisner He acts as an Associate Director at the National Cancer Institute. He serves as an Associate Professor in the Division of Oncology at the University of Texas, San Antonio School of Medicine and is certified by the American Board of Internal Medicine in Internal Medicine and Medical Oncology. He holds an M.D. from the Georgetown University and a B.A. from Rutgers University.

Corporate Headquarters 5820 Nancy Ridge Drive San Diego, California 92121 United States Phone: 858-909-9050 Fax: 858-909-0958 Board Members Memberships Prior Trine Pharmaceuticals, Inc. Director Ontogen Corporation Chairman Avera Pharmaceuticals, Inc. Consultant and Director Adaptive Therapeutics, Inc. Chairman Sequoia Pharmaceuticals, Inc. Director BioVerdant, Inc. Director Symphony Allegro, Inc. 1996-Present Director Anesta Corp. 1999-2008 Former Chairman of the Board Caliper Life Sciences, Inc. 2001-Present Director, Member of Audit Committee and Member of Compensation Committee Tolerx, Inc. 2003-2005 Former Independent Director Sequenom Inc. 2005-N/A Former Member of The Board of Directors Mpex Pharmaceuticals, Inc. 2006-Present Director Kémia, Inc. 2006-N/A Former Director KAI Pharmaceuticals, Inc. 2010-Present Director, Chairperson of Nominating & Governance Committee and Member of Compensation Committee Dynavax Technologies Corporation 2010-Present Chairman, Member of Corporate Governance & Nominating Committee and Member of Executive Compensation & Human Resources Committee Tekmira Pharmaceuticals Corporation 2012-Present Independent Director, Chairman of Compensation Committee and Chairman of R & D Advisory Committee Lpath Inc. Education MD Georgetown University BA Rutgers, The State University of New Jersey Other Affiliations Anesta Corp. Caliper Life Sciences, Inc. Isis Pharmaceuticals, Inc. Trine Pharmaceuticals, Inc. Sequenom Inc. Aberdare Ventures Abbott Laboratories Dynavax Technologies Corporation Tolerx, Inc. Ontogen Corporation Kémia, Inc. Avera Pharmaceuticals, Inc. Georgetown University Rutgers, The State University of New Jersey Franklin Square Hospital Center, Inc. KAI Pharmaceuticals, Inc. Mpex Pharmaceuticals, Inc. Georgetown University School Of Medicine Sequoia Pharmaceuticals, Inc. Lpath Inc. Smithkline Beckman Corporation, Inc. BioVerdant, Inc. Tekmira Pharmaceuticals Corporation Symphony Allegro, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.